This Biophotonics market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The biophotonics market size has grown rapidly in recent years. It will grow from $83.26 billion in 2024 to $92.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to medical imaging advancements, disease diagnosis and monitoring, life sciences research, optical sensing and spectroscopy, laser and light source innovations.
The biophotonics market size is expected to see rapid growth in the next few years. It will grow to $149.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to personalized medicine, precision agriculture, global health initiatives, wearable and mobile health devices, environmental monitoring and safety. Major trends in the forecast period include miniaturization and point-of-care devices, multimodal imaging, optogenetics, machine learning and data analytics, smart imaging probes.
The biophotonics market is experiencing significant growth, driven by the rising demand for minimally invasive surgeries. Advances in optical engineering and imaging technologies are playing a key role in enhancing minimally invasive procedures, allowing for real-time visualization of tissue manipulation at remote internal locations. For example, in January 2023, Intuitive Surgical Inc., a leading US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022. This represents an 18% increase from the 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. The growing number of minimally invasive surgeries performed globally each year is directly contributing to the revenue growth in the biophotonics market.
Anticipated to fuel the biophotonics market's growth is the rising prevalence of chronic conditions. Chronic conditions, characterized by their persistent nature lasting three months or longer, are prevalent worldwide. Biophotonics plays a crucial role in early detection, continuous monitoring, and effective treatment of these conditions, offering non-invasive imaging and diagnostic solutions. This facilitates improved patient outcomes while simultaneously curbing healthcare costs. A September 2022 report from the World Health Organization (WHO) disclosed that chronic diseases are responsible for a significant portion of global mortality, with 74% of all deaths attributed to these conditions. This encompasses a range of chronic diseases, including cardiovascular ailments, cancer, chronic respiratory diseases, and diabetes. Hence, the biophotonics market's growth is spurred by the increasing incidence of chronic conditions.
A notable trend driving the biophotonics market is the introduction of advanced techniques in the field of biotechnology. An exemplary development comes from a team of scientists at the University of St. Andrews in Scotland, who devised a fluorescence microscopy technique. This innovative method allows for the imaging of delicate biological samples with minimal damage, particularly in neuroscience and biomedicine applications. Such low-impact optical techniques are anticipated to revolutionize the realm of biomedicine in the near future. As a result, the biophotonics market is witnessing a growing emphasis on novel and cutting-edge techniques.
Leading companies in the biophotonics market are focusing on developing advanced technological solutions, such as cutting-edge computational tools, to improve imaging precision, enhance diagnostics, and support personalized medicine. Advanced computational tools are specialized software and algorithms designed to analyze complex data from fields like medical imaging and molecular diagnostics. By leveraging machine learning and AI, these tools increase the accuracy and efficiency of biophotonics applications. For example, in July 2023, FOXO Technologies Inc., a US-based biotechnology company, launched bioinformatics services aimed at transforming epigenetic data analysis. These services offer a comprehensive platform designed to meet the needs of clients in academia, healthcare, and the pharmaceutical industry. Key features include the processing and analysis of raw DNA methylation microarray data, along with advanced analyses such as epigenome-wide association studies (EWAS) and AI-driven epigenetic biomarker development.
In May 2024, Bruker Corporation, a US-based manufacturing company, acquired NanoString Technologies for $392.6 million. This acquisition will strengthen Bruker's capabilities in spatial biology, particularly with their nCounter Analysis System, which enables high-sensitivity and precision profiling of gene and protein expression. NanoString Technologies is a US-based provider of life science tools for translational research and molecular diagnostic products.
Biophotonics represents the convergence of photonics and biology, forming a multidisciplinary research field focused on the application of light-based technologies in life sciences and medical domains. Its primary purpose is to investigate, manipulate, and monitor biological processes at multiple levels within the realm of biology, spanning cellular, tissue, molecular, and organismic aspects.
The key technological segments in biophotonics involve in-vitro and in-vivo methodologies. In-vitro approaches are centered around the examination of microorganisms, cells, and biological molecules outside of their natural biological environments. These investigations are typically conducted in laboratory vessels like test tubes, flasks, Petri dishes, and microtiter plates, commonly known as test-tube studies. Various applications within biophotonics encompass see-through imaging, internal imaging, spectromolecular analysis, surface imaging, microscopy, light-based therapies, biosensors, and more, with broad utility across sectors such as diagnostics, therapeutics, testing, and related domains.
The biophotonics market research report is one of a series of new reports that provides biophotonics market statistics, including biophotonics industry global market size, regional shares, competitors with a biophotonics market share, detailed biophotonics market segments, market trends and opportunities, and any further data you may need to thrive in the biophotonics industry. This biophotonics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the biophotonics market include Thermo Fisher Scientific Inc., OpGen Inc., NU Skin Enterprises Inc., IPG Photonics Corporation, Idex Corporation, Toshiba Corporation, Horiba Ltd., Precision Photonics Corp, Roche Group, General Electric Company, Koninklijke Philips NV, Affymetrix Inc., Andor Technology Ltd., Becton Dickinson & Co, Carl Zeiss AG, FEI Company, Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., Zecotek Photonics Inc., Zenalux Biomedical Inc., Glenbrook Technologies Inc., Oxford Instruments PLC, Lumicks BV, Creoptix AG, ThinkCyte Inc., PhotoPharmics Inc., Impedimed Ltd., Bioptics Inc.
North America was the largest region in the biophotonics market in 2024. Western Europe was the second largest region in the biophotonics market. The regions covered in the biophotonics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biophotonics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The biophotonics market size has grown rapidly in recent years. It will grow from $83.26 billion in 2024 to $92.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to medical imaging advancements, disease diagnosis and monitoring, life sciences research, optical sensing and spectroscopy, laser and light source innovations.
The biophotonics market size is expected to see rapid growth in the next few years. It will grow to $149.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to personalized medicine, precision agriculture, global health initiatives, wearable and mobile health devices, environmental monitoring and safety. Major trends in the forecast period include miniaturization and point-of-care devices, multimodal imaging, optogenetics, machine learning and data analytics, smart imaging probes.
The biophotonics market is experiencing significant growth, driven by the rising demand for minimally invasive surgeries. Advances in optical engineering and imaging technologies are playing a key role in enhancing minimally invasive procedures, allowing for real-time visualization of tissue manipulation at remote internal locations. For example, in January 2023, Intuitive Surgical Inc., a leading US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022. This represents an 18% increase from the 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. The growing number of minimally invasive surgeries performed globally each year is directly contributing to the revenue growth in the biophotonics market.
Anticipated to fuel the biophotonics market's growth is the rising prevalence of chronic conditions. Chronic conditions, characterized by their persistent nature lasting three months or longer, are prevalent worldwide. Biophotonics plays a crucial role in early detection, continuous monitoring, and effective treatment of these conditions, offering non-invasive imaging and diagnostic solutions. This facilitates improved patient outcomes while simultaneously curbing healthcare costs. A September 2022 report from the World Health Organization (WHO) disclosed that chronic diseases are responsible for a significant portion of global mortality, with 74% of all deaths attributed to these conditions. This encompasses a range of chronic diseases, including cardiovascular ailments, cancer, chronic respiratory diseases, and diabetes. Hence, the biophotonics market's growth is spurred by the increasing incidence of chronic conditions.
A notable trend driving the biophotonics market is the introduction of advanced techniques in the field of biotechnology. An exemplary development comes from a team of scientists at the University of St. Andrews in Scotland, who devised a fluorescence microscopy technique. This innovative method allows for the imaging of delicate biological samples with minimal damage, particularly in neuroscience and biomedicine applications. Such low-impact optical techniques are anticipated to revolutionize the realm of biomedicine in the near future. As a result, the biophotonics market is witnessing a growing emphasis on novel and cutting-edge techniques.
Leading companies in the biophotonics market are focusing on developing advanced technological solutions, such as cutting-edge computational tools, to improve imaging precision, enhance diagnostics, and support personalized medicine. Advanced computational tools are specialized software and algorithms designed to analyze complex data from fields like medical imaging and molecular diagnostics. By leveraging machine learning and AI, these tools increase the accuracy and efficiency of biophotonics applications. For example, in July 2023, FOXO Technologies Inc., a US-based biotechnology company, launched bioinformatics services aimed at transforming epigenetic data analysis. These services offer a comprehensive platform designed to meet the needs of clients in academia, healthcare, and the pharmaceutical industry. Key features include the processing and analysis of raw DNA methylation microarray data, along with advanced analyses such as epigenome-wide association studies (EWAS) and AI-driven epigenetic biomarker development.
In May 2024, Bruker Corporation, a US-based manufacturing company, acquired NanoString Technologies for $392.6 million. This acquisition will strengthen Bruker's capabilities in spatial biology, particularly with their nCounter Analysis System, which enables high-sensitivity and precision profiling of gene and protein expression. NanoString Technologies is a US-based provider of life science tools for translational research and molecular diagnostic products.
Biophotonics represents the convergence of photonics and biology, forming a multidisciplinary research field focused on the application of light-based technologies in life sciences and medical domains. Its primary purpose is to investigate, manipulate, and monitor biological processes at multiple levels within the realm of biology, spanning cellular, tissue, molecular, and organismic aspects.
The key technological segments in biophotonics involve in-vitro and in-vivo methodologies. In-vitro approaches are centered around the examination of microorganisms, cells, and biological molecules outside of their natural biological environments. These investigations are typically conducted in laboratory vessels like test tubes, flasks, Petri dishes, and microtiter plates, commonly known as test-tube studies. Various applications within biophotonics encompass see-through imaging, internal imaging, spectromolecular analysis, surface imaging, microscopy, light-based therapies, biosensors, and more, with broad utility across sectors such as diagnostics, therapeutics, testing, and related domains.
The biophotonics market research report is one of a series of new reports that provides biophotonics market statistics, including biophotonics industry global market size, regional shares, competitors with a biophotonics market share, detailed biophotonics market segments, market trends and opportunities, and any further data you may need to thrive in the biophotonics industry. This biophotonics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the biophotonics market include Thermo Fisher Scientific Inc., OpGen Inc., NU Skin Enterprises Inc., IPG Photonics Corporation, Idex Corporation, Toshiba Corporation, Horiba Ltd., Precision Photonics Corp, Roche Group, General Electric Company, Koninklijke Philips NV, Affymetrix Inc., Andor Technology Ltd., Becton Dickinson & Co, Carl Zeiss AG, FEI Company, Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., Zecotek Photonics Inc., Zenalux Biomedical Inc., Glenbrook Technologies Inc., Oxford Instruments PLC, Lumicks BV, Creoptix AG, ThinkCyte Inc., PhotoPharmics Inc., Impedimed Ltd., Bioptics Inc.
North America was the largest region in the biophotonics market in 2024. Western Europe was the second largest region in the biophotonics market. The regions covered in the biophotonics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biophotonics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Biophotonics Market Characteristics3. Biophotonics Market Trends and Strategies4. Biophotonics Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Biophotonics Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Biophotonics Market34. Recent Developments in the Biophotonics Market
5. Global Biophotonics Growth Analysis and Strategic Analysis Framework
6. Biophotonics Market Segmentation
7. Biophotonics Market Regional and Country Analysis
8. Asia-Pacific Biophotonics Market
9. China Biophotonics Market
10. India Biophotonics Market
11. Japan Biophotonics Market
12. Australia Biophotonics Market
13. Indonesia Biophotonics Market
14. South Korea Biophotonics Market
15. Western Europe Biophotonics Market
16. UK Biophotonics Market
17. Germany Biophotonics Market
18. France Biophotonics Market
19. Italy Biophotonics Market
20. Spain Biophotonics Market
21. Eastern Europe Biophotonics Market
22. Russia Biophotonics Market
23. North America Biophotonics Market
24. USA Biophotonics Market
25. Canada Biophotonics Market
26. South America Biophotonics Market
27. Brazil Biophotonics Market
28. Middle East Biophotonics Market
29. Africa Biophotonics Market
30. Biophotonics Market Competitive Landscape and Company Profiles
31. Biophotonics Market Other Major and Innovative Companies
35. Biophotonics Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Biophotonics Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on biophotonics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biophotonics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biophotonics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Technology: in-Vitro; in-Vivo2) By Application: See-Through Imaging; Inside Imaging; Spectromolecular; Surface Imaging; Microscopy; Light Therapy; Biosensors; Other Applications
3) By End Use: Diagnostics; Therapeutic; Tests; Other End Uses
Subsegments:
1) By in-Vitro: Diagnostic Imaging; Fluorescence Microscopy; Spectroscopy-Based Detection; Biochemical Sensors; Point-of-Care Devices2) By in-Vivo: Endoscopy; Optical Coherence Tomography (OCT); Photodynamic Therapy (PDT); Bioluminescence Imaging; Near-Infrared Spectroscopy (NIRS)
Key Companies Mentioned: Thermo Fisher Scientific Inc.; OpGen Inc.; NU Skin Enterprises Inc.; IPG Photonics Corporation; Idex Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Biophotonics market report include:- Thermo Fisher Scientific Inc.
- OpGen Inc.
- NU Skin Enterprises Inc.
- IPG Photonics Corporation
- Idex Corporation
- Toshiba Corporation
- Horiba Ltd.
- Precision Photonics Corp
- Roche Group
- General Electric Company
- Koninklijke Philips NV
- Affymetrix Inc.
- Andor Technology Ltd.
- Becton Dickinson & Co
- Carl Zeiss AG
- FEI Company
- Hamamatsu Photonics KK
- Lumenis Ltd.
- Olympus Corporation
- PerkinElmer Inc.
- Zecotek Photonics Inc.
- Zenalux Biomedical Inc.
- Glenbrook Technologies Inc.
- Oxford Instruments Plc
- Lumicks BV
- Creoptix AG
- ThinkCyte Inc.
- PhotoPharmics Inc.
- Impedimed Ltd.
- Bioptics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 92.33 Billion |
| Forecasted Market Value ( USD | $ 149.06 Billion |
| Compound Annual Growth Rate | 12.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
